Chemeq names new CEO
Tuesday, 26 July, 2005
Antimicrobial specialist Chemeq (ASX:CMQ) has named David Williams its new CEO and director, commencing August 1. Williams was formerly CEO of Epic Energy, a gas transmission company.
Chemeq's founder scientist, Graham Melrose, will remain executive chairman until a new chairman is appointed.
The company also announced that it has banked AUD$20 million after the allotment of 20,000 convertible bonds with a face value of $1000 each to Mizuho International, Stark Trading and Shepherd Investments. An aggregate additional subscription fee of $350,000 has been paid to the three companies.
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
